STMED - medicine training simulator

• Grant number: 21/09184-3
• Support Opportunities: Research Grants - Innovative Research in Small Business - PIPE
• Start date: February 01, 2022
• End date: October 31, 2022
• Field of knowledge: Health Sciences - Medicine - Medical Clinics
• Principal Investigator: Andrey Omar Mozo Uscamayta
• Grantee: Andrey Omar Mozo Uscamayta
• Company: Innolution Sistemas de Informática Ltda
• CNAE: Atividades de apoio à educação ; Atividades de serviços de complementação diagnóstica e terapêutica ; Atividades de atenção à saúde humana não especificadas anteriormente
• City: Ribeirão Preto
• Associated researchers: Gerson Hiroshi Yoshinari Júnior
• Associated scholarship(s): 22/00706-0 - STMED: Medicine training simulator, BP.PIPE

Abstract

With the sudden appearance of the COVID-19 pandemic in the world, the use of Telemedicine solutions has become necessary in order to minimize the patient access contingency in medical centers. Although the use telemedicine solutions for patient care it is becoming more and more common, there is still a large gap in telemedicine solutions focused on supporting and training of residents and students. Particularly in radiotherapy, professionals can only use specialized software present in medical centers with totally limitated remote access. This difficulty is even greater with residents and students who need to train on equipmenta used for treatment production. There is a huge need for training residents in radiotherapy to have more expertise in the delineation phases of contouring anatomical regions, risk organs, and tumor areas. The contouring phase is one of the most important in the planning process of a radiotherapy treatment (teletherapy). Possible errors in this phase could lead to errors during the entire planning and treatment of the patient mainly because this phase minimizes the exposure of healthy tissue to radiation. Contouring systems offer the possibility to show the human body in 3D, which helps on the identification of location and size of both cancerous tumors and organs at risk. (AU)